Skip to main content
Genmab logo

Genmab — Investor Relations & Filings

Ticker · GMAB ISIN · DK0010272202 LEI · 529900MTJPDPE4MHJ122 CO Manufacturing
Open in API
Filings indexed 2,816 across all filing types
Latest filing 2024-03-15 Transaction in Own Shar…
Country DK Denmark
Listing CO GMAB

About Genmab

https://www.genmab.com/

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares 2024
Transaction in Own Shares Classification · 1% confidence The document is titled "Genmab Announces Initiation of Share Buy-Back Program" and details the plan to repurchase up to DKK 3.5 billion worth of shares. This action directly relates to the company managing its own outstanding shares, which falls under the definition of a share repurchase or transaction in own shares. The filing type code corresponding to this activity is 'POS' (Transaction in Own Shares). The document length (6664 chars) is substantial enough that it is the primary announcement itself, not just a brief notice of publication (RPA/RNS).
2024-03-15 English
Genmab Announces Initiation of Share Buy-Back Program
Transaction in Own Shares Classification · 1% confidence The document is a formal announcement by Genmab A/S regarding the initiation of a share buy-back program. It details the terms, timeframe, and regulatory compliance (MAR/Safe Harbour) of the program. While it mentions an attachment, the text itself provides the full details of the program initiation, which is a standard corporate action announcement. Under the provided definitions, announcements regarding a company buying back its own shares are classified as 'Transaction in Own Shares' (POS).
2024-03-15 English
6-K
Foreign Filer Report
2024-03-13 English
Director's Dealing 2024
Director's Dealing Classification · 1% confidence The document explicitly states it discloses transactions in company shares made by managerial employees and their closely associated persons, referencing Article 19 of Regulation No. 596/2014 (Market Abuse Regulation). This type of filing, detailing insider trading or transactions by management/directors, directly corresponds to the definition of Director's Dealing (DIRS). Although it is a 'Company Announcement', the specific content points to DIRS rather than a general Regulatory Filing (RNS) or a Report Publication Announcement (RPA), as it contains the substance of the required disclosure, not just an announcement that a report is attached.
2024-03-13 English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
Director's Dealing Classification · 1% confidence The document is a formal notification of transactions in company shares and linked securities (Restricted Stock Units) by managerial employees and board members of Genmab A/S. It explicitly references Article 19 of Regulation No. 596/2014 on Market Abuse, which is the standard regulatory framework for reporting insider/director dealings. The content consists of a series of standardized tables detailing the names, positions, and transaction specifics for each individual, which is the hallmark of a Director's Dealing (DIRS) filing.
2024-03-13 English
6-K
Foreign Filer Report
2024-03-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.